|
2003 Journal Article Expression of the HPV16E7 oncoprotein by thymic epithelium is accompanied by disrupted T cell maturation and a failure of the thymus to involute with ageMalcolm, K. M., Gill, J., Leggatt, G. R., Boyd, R., Lambert, P. and Frazer, I. H. (2003). Expression of the HPV16E7 oncoprotein by thymic epithelium is accompanied by disrupted T cell maturation and a failure of the thymus to involute with age. Clinical and Developmental Immunology, 10 (2-4), 91-103. doi: 10.1080/10446670310001626562 |
|
2003 Journal Article Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?Graham, H. Kerr, Boyd, Roslyn N. and Fehlings, Darcy (2003). Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?. Medical Journal of Australia, 178 (2), 95-96. |
|
2003 Journal Article Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?Graham, HK, Boyd, RN and Fehlings, D (2003). Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?. Medical Journal of Australia, 178 (2), 95-96. |
|
2002 Journal Article Hip displacement in spastic cerebral palsy: Repeatability of radiologic measurementParrott, Jennifer, Boyd, Roslyn N., Dobson, Fiona, Lancaster, Ann, Love, Sarah, Oates, Jenene, Wolfe, Rory, Nattrass, Gary R. and Graham, H. Kerr (2002). Hip displacement in spastic cerebral palsy: Repeatability of radiologic measurement. Journal of Pediatric Orthopaedics, 22 (5), 660-667. doi: 10.1097/01.BPO.0000023144.69745.67 |
|
2002 Journal Article Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial Botolinum toksin A'nin analjezik etkileri: Rastgele gruplamali, plasebo kontrollü klinik çalişmaBarwood, S., Baillieu, C., Boyd, R., Brereton, K., Low, J., Nattrass, G. and Graham, H. Kerr (2002). Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial Botolinum toksin A'nin analjezik etkileri: Rastgele gruplamali, plasebo kontrollü klinik çalişma. Agri, 14 (3), 29-36. |
|
2002 Journal Article Hip surveillance in children with cerebral palsy - Impact on the surgical management of spastic hip diseaseDobson, F., Boyd, R. N., Parrott, J., Nattrass, G. R. and Graham, H. K. (2002). Hip surveillance in children with cerebral palsy - Impact on the surgical management of spastic hip disease. Journal of Bone and Joint Surgery - Series B, 84B (5), 720-726. doi: 10.1302/0301-620X.84B5.12398 |
|
2001 Conference Publication Management of upper limb dysfunction in children with cerebral palsy: a systematic reviewBoyd, R. N., Morris, M. E. and Graham, H. K. (2001). Management of upper limb dysfunction in children with cerebral palsy: a systematic review. Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination, Lake Maggiore, Italy, June 2000. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1046/j.1468-1331.2001.00048.x |
|
2001 Conference Publication The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trialBoyd, R. N., Dobson, F., Parrott, J., Love, S., Oates, J., Larson, A., Burchall, G., Chondros, P., Carlin, J., Nattrass, G. and Graham, H. K. (2001). The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial. Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination, Lake Maggiore, Italy, June 2000. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1046/j.1468-1331.2001.00043.x |
|
2001 Conference Publication Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic reviewBoyd, R. N. and Hays, R. M. (2001). Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review. Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination, Lake Maggiore, Italy, June 2000. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1046/j.1468-1331.2001.00034.x |
|
2001 Conference Publication Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluationHoultram, J., Noble, I., Boyd, R. N., Corry, I., Flett, P. and Graham, H. K. (2001). Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation. Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination, Lake Maggiore, Italy, June 2000. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1046/j.1468-1331.2001.00052.x |
|
2001 Conference Publication Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH-2 approachBoyd, R. N. and Hays, R. M. (2001). Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH-2 approach. Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination, Lake Maggiore, Italy, June 2000. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1046/j.1468-1331.2001.00049.x |
|
2000 Journal Article Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trialBarwood, S., Baillieu, C., Boyd, R., Brereton, K., Low, J., Nattrass, G. and Graham, H. K. (2000). Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Developmental Medicine and Child Neurology, 42 (2), 116-121. doi: 10.1111/j.1469-8749.2000.tb00056.x |
|
2000 Journal Article Recommendations for the use of botulinum toxin type A in the management of cerebral palsyGraham, H. K., Aoki, K. R., Autti-Ramo, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., Matthews, D., Molenaers, G., Motta, F., Ruiz, P. J. G. and Wissel, J. (2000). Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait and Posture, 11 (1), 67-79. doi: 10.1016/S0966-6362(99)00054-5 |
|
2000 Journal Article Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsyBoyd, R. N., Pliatsios, V., Starr, R., Wolfe, R. and Graham, H. K. (2000). Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Developmental Medicine and Child Neurology, 42 (1), 32-41. doi: 10.1111/j.1469-8749.2000.tb00022.x |
|
1999 Journal Article Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsyBoyd, R. N., Graham, J. E. A., Nattrass, G. R. and Graham, H. K. (1999). Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. European Journal of Neurology, 6 (S4), S37-S45. doi: 10.1111/j.1468-1331.1999.tb00033.x |
|
1999 Journal Article Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsyBoyd, R. N. and Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology, 6 (Suppl. 4), S23-S35. doi: 10.1111/j.1468-1331.1999.tb00031.x |
|
1999 Journal Article High- or low-technology measurements of energy expenditure in clinical gait analysis?Boyd, R., Fatone, S., Rodda, J., Olesch, C., Starr, R., Cullis, E., Gallagher, D., Carlin, J. B., Nattrass, G. R. and Graham, K. (1999). High- or low-technology measurements of energy expenditure in clinical gait analysis?. Developmental Medicine and Child Neurology, 41 (10), 676-682. doi: 10.1111/j.1469-8749.1999.tb00522.x |
|
1998 Conference Publication Biomechanical transformation of the gastrosoleus muscle by injection of botulinum toxin A in ambulant children with cerebral palsyBoyd, R., Pliatsios, V., Starr, R., Nattrass, G. and Graham, H. K. (1998). Biomechanical transformation of the gastrosoleus muscle by injection of botulinum toxin A in ambulant children with cerebral palsy. -, -, 1998. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0966-6362(98)90243-0 |
|
1997 Journal Article The hip in children with cerebral palsy: Predicting the outcome of soft tissue surgeryCornell, M. S., Hatrick, N. C., Boyd, R., Baird, G. and Spencer, J. D. (1997). The hip in children with cerebral palsy: Predicting the outcome of soft tissue surgery. Clinical Orthopaedics And Related Research, 340 (340), 165-171. |
|
1997 Conference Publication Biomechanical transformation of the gastrocnemius muscle by injection of Botulinum toxin A and casting in ambulant children with cerebral palsyBoyd, R. N., Pliatsios, V., Starr, R. and Graham, H. K. (1997). Biomechanical transformation of the gastrocnemius muscle by injection of Botulinum toxin A and casting in ambulant children with cerebral palsy. International Meeting of the European Society for Movement Analysis in Children, Basel, Switzerland, 13–15 November 1997. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0966-6362(97)90078-3 |
